Clearmind Medicine Inc. (CMND)

Clearmind Medicine Balance Sheet

Financials in millions CAD. Fiscal year is November - October.

Year	2023	2022	2021	2020
Cash & Equivalents	5.43	0.13	4.6	0.33
Short-Term Investments	0.09	0.19	0	0
Cash & Cash Equivalents	5.51	0.32	4.6	0.33
Cash Growth	1609.58%	-92.99%	1294.44%	-
Receivables	0.1	0.05	0.16	0
Other Current Assets	0.18	0.06	0.16	0
Total Current Assets	5.79	0.43	4.92	0.33
Property, Plant & Equipment	0	0.05	0.02	0
Long-Term Investments	0.04	0.01	0.02	0
Goodwill and Intangibles	0.12	0.13	0.2	0
Other Long-Term Assets	0	0.2	0	0
Total Long-Term Assets	0.16	0.39	0.24	0
Total Assets	5.95	0.83	5.16	0.33
Accounts Payable	0.66	1.6	0.36	0.01
Current Debt	0	0.04	0	0
Other Current Liabilities	4.31	0.29	0	0
Total Current Liabilities	4.97	1.93	0.36	0.01
Total Liabilities	4.97	1.93	0.36	0.01
Total Debt	0	0.04	0	0
Retained Earnings	-18.77	-10.15	-4.44	-0.72
Comprehensive Income	-0.02	-0.02	0	0
Shareholders' Equity	0.98	-1.11	4.8	0.32
Net Cash / Debt	5.51	0.28	4.6	0.33
Net Cash / Debt Growth	1840.56%	-93.82%	1294.44%	-
Net Cash Per Share	27.23	6.56	148.80	18.19
Working Capital	0.82	-1.5	4.56	0.32
Book Value Per Share	4.86	-25.52	155.34	17.63

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).